Phase I/II study of CTAP101 Capsules for the treatment of vitamin D insufficiency in chronic kidney disease (CKD)

Trial Profile

Phase I/II study of CTAP101 Capsules for the treatment of vitamin D insufficiency in chronic kidney disease (CKD)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Calcifediol (Primary)
  • Indications Vitamin D deficiency
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Jan 2017 According to OPKO Health website, this trial was originally conducted by Cytochroma which later on was acquired by OPKO Health and now the name changed to OPKO Renal in March 2013.
    • 27 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top